22 studies found for:    "desmoid tumor"
Show Display Options
Rank Status Study
21 Completed Imatinib Mesylate And Cyclophosphamide In Metronomic Administration: Dose Escalation Study Of Imatinib Mesylate
Condition: Cancer
Interventions: Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 1 );   Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 2);   Drug: Imatinib mesylate, Cyclophosphamide (Dosing level 3);   Procedure: Blood sampling
22 Not yet recruiting Prospective Trial Comparing the Performance Profiles of Two Non-Cross-Linked Porcine Dermal Matrices in Abdominal Wall Reconstruction
Conditions: Hernia, Ventral;   Intestinal Fistula;   Fibromatosis, Abdominal
Interventions: Procedure: Abdominal wall reconstruction with Strattice;   Other: Assess pain intensity at last office visit preoperatively;   Other: Assess pain interference at last office visit preoperatively;   Other: Assess physical functioning at last office visit preoperatively;   Other: Assess patient quality of life at last office visit preoperatively;   Other: Assess patient pain intensity postoperatively;   Other: Assess pain interference postoperatively;   Other: Assess physical functioning postoperatively;   Other: Assess quality of life postoperatively;   Other: Assess hernia recurrence at 30 days postoperatively;   Other: Assess bulge at 30 days postoperatively;   Other: Assess Surgical Site Occurrences at 30 days postoperatively;   Other: Assess hernia recurrence at 1 year postoperatively;   Other: Assess bulge at 1 year postoperatively;   Other: Assess Surgical Site Occurrences at 1 year postoperatively;   Other: Assess overall complications at 30 days postoperatively;   Other: Assess overall complications at 1 year postoperatively;   Procedure: Abdominal wall reconstruction with XenMatrix;   Device: Strattice;   Device: XenMatrix

Show previous page of results Previous Page (1-20) Studies Shown (21-22) Next Page
Indicates status has not been verified in more than two years